<DOC>
	<DOCNO>NCT01429818</DOCNO>
	<brief_summary>The Purpose study evaluate effect combination glimepiride/metformin endothelial dysfunction ( ED ) asymptomatic patient type 2 diabetes mellitus ( DM ) use 13N-ammonia-positron emission tomography ( PET ) .</brief_summary>
	<brief_title>Endothelial Disfunction Treatment With Glimepiride/Metformin Combination ( Glimetal ) Type 2 Diabetes Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Glimepiride</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Both gender At least 18 year old Type 2 diabetes mellitus diagnosis Signed Informed Consent History smoking , hypertension , dyslipidemia , ischemic heart disease autoimmune rheumatic disease Pregnancy lactation History abuse and/or substance dependence within 6 month precede survey . History glimepiride metformin allergy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Endothelial dysfunction</keyword>
	<keyword>Diabetes mellitus</keyword>
	<keyword>glimepiride</keyword>
	<keyword>metformin</keyword>
</DOC>